Remodelling of Ca2+ transport in cancer: How it contributes to cancer hallmarks?

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 369, Issue 1638, 2014, Pages

  Prevarskaya, Natalia ^a,b   Ouadid Ahidouch, Halima ^c   Skryma, Roman ^a   Shuba, Yaroslav ^d,e  

^a Université des Sciences et Technologies de Lille   (France)

^b Laboratory of Excellence in Ion Channel Science and Therapeutics   (France)

^c Université Picardie Jules Vernes   (France)

^d BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^e State Key Laboratory of Molecular and Cellular Biology   (Ukraine)

Author keywords

Apoptosis; Calcium signalling; Cancer; Metastasis; Migration; Proliferation

Indexed keywords

APOPTOSIS; BIOCHEMISTRY; CALCIUM; CANCER; CATION; CHEMICAL BINDING; CYTOLOGY; DISEASE TREATMENT; HOMEOSTASIS; PATHOLOGY; PHYSIOLOGY; PROTEOMICS; SIGNALING;

CALCIUM; CALCIUM CHANNEL;

APOPTOSIS; BIOLOGICAL MODEL; CALCIUM SIGNALING; CELL PROLIFERATION; HUMAN; METABOLISM; METASTASIS; MIGRATION; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; PROLIFERATION; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

APOPTOSIS; CALCIUM SIGNALLING; CANCER; METASTASIS; MIGRATION; PROLIFERATION;

APOPTOSIS; BIOLOGICAL TRANSPORT; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CELL PROLIFERATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84893441567     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2013.0097     Document Type: Review

References (103)

1. Berridge MJ, Bootman MD, Lipp P. 1998 Calcium-a life and death signal. Nature 395, 645-648. (doi:10.1038/27094)
2. McConkey DJ, Orrenius S. 1997 The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Commun. 239, 357-366. (doi:10.1006/bbrc. 1997.7409)
3. Zhivotovsky B, Orrenius S. 2011 Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium 50, 211-221. (doi:10.1016/j.ceca.2011.03.003)
4. Orrenius S, Zhivotovsky B, Nicotera P. 2003 Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell. Biol. 4, 552-565. (doi:10.1038/nrm1150)
5. 2+ homeostasis in apoptotic resistance of prostate cancer cells. Biochem. Biophys. Res. Commun. 322, 1326-1335. (doi:10.1016/j.bbrc.2004.08.037)
6. Berridge MJ, Lipp P, Bootman MD. 2000 The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell. Biol. 1, 11-21. (doi:10.1038/35036035)
7. Berridge MJ, Bootman MD, Roderick HL. 2003 Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell. Biol. 4, 517-529. (doi:10.1038/nrm1155)
8. Allbritton NL, Meyer T. 1993 Localized calcium spikes and propagating calcium waves. Cell Calcium 14, 691-697. (doi:10.1016/0143-4160(93)90095-N)
9. 2+ signals. J. Cell. Sci. 114, 2213-2222.
10. 2+ signalling and control of growth and proliferation. Biol. Cell. 96, 55-68. (doi:10.1016/j.biolcel.2003.11.001)
11. Munaron L, Antoniotti S, Lovisolo D. 2004 Intracellular calcium signals and control of cell proliferation: how many mechanisms? J. Cell. Mol. Med. 8, 161-168. (doi:10.1111/j.1582-4934.2004. tb00271.x)
12. Capiod T, Shuba Y, Skryma R, Prevarskaya N. 2007 Calcium signalling and cancer cell growth. Subcell. Biochem. 45, 405-427. (doi:10.1007/978-1-4020-6191-2_15)
13. Chen YF, Chiu WT, Chen YT, Lin PY, Huang HJ, Chou CY, Chang HC, Tang MJ, Shen MR. 2011 Calcium store sensor stromal-interaction molecule 1-dependent signalling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc. Natl Acad. Sci. USA 108, 15 225-15 230. (doi:10.1073/pnas.1017998108)
14. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 8, 361-375. (doi:10.1038/nrc2374)
15. Hanahan D, Weinberg RA. 2000 The hallmarks of cancer. Cell 100, 57-70. (doi:10.1016/S0092-8674(00)81683-9)
16. Prevarskaya N, Skryma R, Shuba Y. 2010 Ion channels and the hallmarks of cancer. Trends Mol. Med. 16, 107-121. (doi:10.1016/j.molmed.2010. 01.005)
17. 2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res. 66, 2038-2047. (doi:10.1158/0008-5472.CAN-05-0376)
18. Lehen'kyi V, Raphaël M, Prevarskaya N. 2012 The role of the TRPV6 channel in cancer. J. Physiol. 590, 1369-1376. (doi:10.1113/jphysiol.2011. 225862)
19. 2+/NFAT-dependent pathways. Oncogene 26, 7380-7385. (doi:10.1038/sj.onc. 1210545)
20. Lehen'kyi V et al. 2011 TRPV6 determines the effect of vitamin D3 on prostate cancer cell growth. PLoS ONE 6, e16856. (doi:10.1371/journal.pone.0016856)
21. Kim SY et al. 2013 Regulation of calcium influx and signalling pathway in cancer cells via TRPV6-Numb1 interaction. Cell Calcium 53, 102-111. (doi:10.1016/j.ceca.2012.10.005)
22. 2+/calcineurin signalling pathway. EMBO J. 25, 3714-3724. (doi:10.1038/sj.emboj.7601246)
23. Motiani RK, Abdullaev IF, Trebak M. 2010 A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptornegative breast cancer cells. J. Biol. Chem. 285, 19 173-19 183. (doi:10.1074/jbc.M110.102582)
24. Faouzi M, Hague F, Potier M, Ahidouch A, Sevestre H, Ouadid-Ahidouch H. 2011 Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. J. Cell. Physiol. 226, 542-551. (doi:10.1002/jcp.22363)
25. Faouzi M, Kischel P, Hague F, Ahidouch A, Benzerdjeb N, Sevestre H, Penner R, Ouadid-Ahidouch H. 2013 ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells. Biochim. Biophys. Acta 1833, 752-760. (doi:10.1016/j.bbamcr.2012. 12.009)
26. 2+-ATPases 2B involvement in human prostate cancer cell growth control. J. Biol. Chem. 276, 47 608-47 614. (doi:10.1074/jbc. M107011200)
27. Feng M et al. 2010 Store-independent activation of Orai1 by SPCA2 in mammary tumours. Cell 143, 84-98. (doi:10.1016/j.cell.2010.08.040)
28. Roberts-Thomson SJ, Curry MC, Monteith GR. 2010 Plasma membrane calcium pumps and their emerging roles in cancer. World J. Biol. Chem. 1, 248-253. (doi:10.4331/wjbc.v1.i8.248)
29. Sakakura C et al. 2003 Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers. Anticancer Res. 23, 3691-3697.
30. 2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol. Cancer 9, 156. (doi:10.1186/1476-4598-9-156)
31. Abdul M, Ramlal S, Hoosein N. 2008 Ryanodine receptor expression correlates with tumour grade in breast cancer. Pathol. Oncol. Res. 14, 157-160. (doi:10.1007/s12253-008-9045-9)
32. Hou MF et al. 2011 Orai1/CRACM1 overexpression suppresses cell proliferation via attenuation of the store-operated calcium influx-mediated signalling pathway in A549 lung cancer cells. Biochim. Biophys. Acta 1810, 1278-1284. (doi:10.1016/j. bbagen.2011.07.001)
33. Liu H, Hughes JD, Rollins S, Chen B, Perkins E. 2011 Calcium entry via ORAI1 regulates glioblastoma cell proliferation and apoptosis. Exp. Mol. Pathol. 91, 753-760. (doi:10.1016/j.yexmp. 2011.09.005)
34. Panner A, Wurster RD. 2006 T-type calcium channels and tumour proliferation. Cell Calcium 40, 253-259. (doi:10.1016/j.ceca.2006.04.029)
35. 2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration. Br. J. Pharmacol. 166, 1247-1260. (doi:10.1111/j.1476-5381.2012.01852.x)
36. Prevarskaya N, Zhang L, Barritt G. 2007 TRP channels in cancer. Biochim. Biophys. Acta 1772, 937-946. (doi:10.1016/j.bbadis.2007.05.006)
37. Aydar E, Yeo S, Djamgoz M, Palmer C. 2009 Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy. Cancer Cell Int. 9, 23. (doi:10.1186/1475-2867-9-23)
38. Wang Y, Yue D, Li K, Liu YL, Ren CS, Wang P. 2010 The role of TRPC6 in HGF-induced cell proliferation of human prostate cancer DU145 and PC3 cells. Asian J. Androl. 12, 841-852. (doi:10.1038/aja. 2010.85)
39. Ding X, He Z, Shi Y, Wang Q, Wang Y. 2010 Targeting TRPC6 channels in oesophageal carcinoma growth. Expert Opin. Ther. Targets 14, 513-527. (doi:10.1517/14728221003733602)
40. Dhennin-Duthille I, Gautier M, Faouzi M, Guilbert A, Brevet M, Vaudry D, Ahidouch A, Sevestre H, Ouadid-Ahidouch H. 2011 High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol. Biochem. 28, 813-822. (doi:10.1159/000335795)
41. Zeng X et al. 2010 Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis. 13, 195-201. (doi:10.1038/pcan.2009.55)
42. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H. 2009 Evidence that TRPM7 is required for breast cancer cell proliferation. Am. J. Physiol. 297, C493-C502. (doi:10.1152/ajpcell.00624.2008)
43. Yang ZH, Wang XH, Wang HP, Hu LQ. 2009 Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells. Asian J. Androl. 11, 157-165. (doi:10.1038/aja.2009.1)
44. Rao RV, Ellerby HM, Bredesen DE. 2004 Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 11, 372-380. (doi:10.1038/sj.cdd.4401378)
45. Flourakis M et al. 2010 Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells. Cell Death Dis. 1, e75. (doi:10.1038/cddis.2010.52)
46. Berry PA, Birnie R, Droop AP, Maitland NJ, Collins AT. 2011 The calcium sensor STIM1 is regulated by androgens in prostate stromal cells. Prostate 71, 1646-1655. (doi:10.1002/pros.21384)
47. 2+binding protein abundantly expressed and regulated by androgen in prostatic epithelial cells. Endocrinology 139, 4337-4344. (doi:10.1210/en. 139.10.4337)
48. 2+ homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1, 169-179. (doi:10.1016/S1535-6108(02)00034-X)
49. 2+ homeostasis and apoptotic resistance of neuroendocrinedifferentiated prostate cancer cells. Cell Death Differ. 11, 321-330. (doi:10.1038/sj.cdd.4401375)
50. Schaefer EA, Stohr S, Meister M, Aigner A, Gudermann T, Buech TR. 2013 Stimulation of the chemosensory TRPA1 cation channel by volatile toxic substances promotes cell survival of small cell lung cancer cells. Biochem. Pharmacol. 85, 426-438. (doi:10.1016/j.bcp.2012.11.019)
51. 2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents deathinducing signalling complex formation. Proc. Natl Acad. Sci. USA 108, 19 072-19 077. (doi:10.1073/pnas.1018310108)
52. Stock K et al. 2012 Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. Nat. Med. 18, 1232-1238. (doi:10.1038/nm.2827)
53. Amantini C, Mosca M, Nabissi M, Lucciarini R, Caprodossi S, Arcella A, Giangaspero F, Santoni G. 2007 Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J. Neurochem. 102, 977-990. (doi:10.1111/j.1471-4159.2007.04582.x)
54. Tsunoda T et al. 2005 Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines. Oncogene 24, 1396-1402. (doi:10.1038/sj.onc.1208313)
55. Rong YP, Barr P, Yee VC, Distelhorst CW. 2009 Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. Biochim. Biophys. Acta 1793, 971-978. (doi:10.1016/j.bbamcr.2008.10.015)
56. Rong YP et al. 2009 The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc. Natl Acad. Sci. USA 106, 14 397-14 402. (doi:10.1073/pnas.0812352106)
57. Holton M, Yang D, Wang W, Mohamed TM, Neyses L, Armesilla AL. 2007 The interaction between endogenous calcineurin and the plasma membrane calcium-dependent ATPase is isoform specific in breast cancer cells. FEBS Lett. 581, 4115-4119. (doi:10.1016/j.febslet.2007.07.054)
58. Baggott RR et al. 2012 Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells. Carcinogenesis 33, 2362-2368. (doi:10.1093/carcin/bgs282)
59. Curry MC, Luk NA, Kenny PA, Roberts-Thomson SJ, Monteith GR. 2012 Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells. J. Biol. Chem. 287, 28 598-28 608. (doi:10.1074/jbc.M112.364737)
60. 2+ in autophagy regulation. Cell Calcium 50, 242-250. (doi:10.1016/j.ceca.2011.04.001)
61. 2+ signals in autophagy. Cell Calcium 52, 44-51. (doi:10.1016/j.ceca.2012.03.001)
62. 2+ transfer to mitochondria. Cell 142, 270-283. (doi:10.1016/j.cell.2010.06.007)
63. Prevarskaya N, Skryma R, Shuba Y. 2011 Calcium in tumour metastasis: new roles for known actors. Nat. Rev. Cancer 11. 609-618. (doi:10.1038/nrc3105)
64. 2+-mediated motility of human pancreatic duct cells. Am. J. Physiol. 299, C1493-C1503. (doi:10.1152/ajpcell.00242.2010)
65. Su LT, Agapito MA, Li M, Simonson WT, Huttenlocher A, Habas R, Yue L, Runnels LW. 2006 TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J. Biol. Chem. 281, 11 260-11 270. (doi:10.1074/jbc. M512885200)
66. Wei C, Wang X, Chen M, Ouyang K, Song LS, Cheng H. 2009 Calcium flickers steer cell migration. Nature 457, 901-905. (doi:10.1038/nature07577)
67. 2+ influx. Cell Calcium 47, 425-432. (doi:10.1016/j. ceca.2010.03.003)
68. Gao H, Chen X, Du X, Guan B, Liu Y, Zhang H. 2011 EGF enhances the migration of cancer cells by upregulation of TRPM7. Cell Calcium 50, 559-568. (doi:10.1016/j.ceca.2011.09.003)
69. Wei C, Wang X, Zheng M, Cheng H. 2012 Calcium gradients underlying cell migration. Curr. Opin. Cell Biol. 24, 254-261. (doi:10.1016/j.ceb.2011.12.002)
70. Middelbeek J et al. 2012 TRPM7 is required for breast tumour cell metastasis. Cancer Res. 72, 4250-4261. (doi:10.1158/0008-5472.CAN-11-3863)
71. Rybarczyk P et al. 2012 Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. Int. J. Cancer 131, E851-E861. (doi:10.1002/ijc.27487)
72. Wondergem R, Ecay TW, Mahieu F, Owsianik G, Nilius B. 2008 HGF/SF and menthol increase human glioblastoma cell calcium and migration. Biochem. Biophys. Res. Commun. 372, 210-215. (doi:10.1016/j.bbrc.2008.05.032)
73. Okamoto Y, Ohkubo T, Ikebe T, Yamazaki J. 2012 Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines. Int. J. Oncol. 40, 1431-1440.
74. Waning J, Vriens J, Owsianik G, Stüwe L, Mally S, Fabian A, Frippiat C, Nilius B, Schwab A. 2007 A novel function of capsaicin-sensitive TRPV1 channels: involvement in cell migration. Cell Calcium 42, 17-25. (doi:10.1016/j.ceca.2006.11.005)
75. Monet M et al. 2010 Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res. 70, 1225-1235. (doi:10.1158/0008-5472.CAN-09-2205)
76. Yang S, Zhang JJ, Huang XY. 2009 Orai1 and STIM1 are critical for breast tumour cell migration and metastasis. Cancer Cell 15, 124-134. (doi:10.1016/j.ccr.2008.12.019)
77. + channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J. Cell Physiol. 227, 3837-3846. (doi:10.1002/jcp.24095)
78. 2+ sensor STIM1 regulates actomyosin contractility of migratory cells. J. Cell Sci. 126, 1260-1267.
79. Motiani RK, Hyzinski-García MC, Zhang X, Henkel MM, Abdullaev IF, Kuo YH, Matrougui K, Mongin AA, Trebak M. 2013 STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion. Pflugers Arch. 465, 1249-1260. (doi:10.1007/s00424-013-1254-8)
80. Huang JB, Kindzelskii AL, Clark AJ, Petty HR. 2004 Identification of channels promoting calcium spikes and waves in HT1080 tumour cells: their apparent roles in cell motility and invasion. Cancer Res. 64, 2482-2489. (doi:10.1158/0008-5472.CAN-03-3501)
81. Santoni G, Caprodossi S, Farfariello V, Liberati S, Gismondi A, Amantini C. 2012 Antioncogenic effects of transient receptor potential vanilloid 1 in the progression of transitional urothelial cancer of human bladder. ISRN Urol. 2012, 458238.
82. Kang SS et al. 2010 Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res. 70, 1173-1183. (doi:10.1158/0008-5472.CAN-09-2886)
83. Mueller A, Bächi T, Höchli M, Schäfer BW, Heizmann CW. 1999 Subcellular distribution of S100 proteins in tumour cells and their relocation in response to calcium activation. Histochem. Cell Biol. 111, 453-459. (doi:10.1007/s004180050381)
84. Carmeliet P. 2005 VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl. 3), 4-10. (doi:10.1159/000088478)
85. Ellis LM, Hicklin DJ. 2008 VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8, 579-591. (doi:10.1038/nrc2403)
86. Saylor PJ, Escudier B, Michaelson MD. 2012 Importance of fibroblast growth factor receptor in neovascularisation and tumour escape from antiangiogenic therapy. Clin. Genitourin. Cancer 10, 77-83. (doi:10.1016/j.clgc.2012.01.010)
87. Munaron L. 2006 Intracellular calcium, endothelial cells and angiogenesis. Recent Pat. Anticancer Drug Discov. 1, 105-119. (doi:10.2174/1574892067 75246502)
88. Fiorio Pla A, Avanzato D, Munaron L, Ambudkar IS. 2012 Ion channels and transporters in cancer. 6. Vascularizing the tumour: TRP channels as molecular targets. Am. J. Physiol. 302, C9-C15. (doi:10.1152/ajpcell.00280.2011)
89. Munaron L, Genova T, Avanzato D, Antoniotti S, Fiorio Pla A. 2013 Targeting calcium channels to block tumour vascularisation. Recent Pat. Anticancer Drug Discov. 8, 27-37.
90. Faehling M, Kroll J, Föhr KJ, Fellbrich G, Mayr U, Trischler G, Waltenberger J. 2002 Essential role of calcium in vascular endothelial growth factor Ainduced signalling: mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J. 16, 1805-1807.
91. 2+ entry and endothelial tube formation. Circ. Res. 108, 1190-1198. (doi:10.1161/CIRCRESAHA.111.243352)
92. 2+ concentration. Stem Cells 29, 1898-1907. (doi:10.1002/stem.734)
93. Clinical Trials database search results. See http://clinicaltrials.gov/ct2/results?term=carboxyamidotriazole (last accessed 30 April 2013).
94. Enfissi A, Prigent S, Colosetti P, Capiod T. 2004 The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells. Cell Calcium 36, 459-467. (doi:10.1016/j.ceca.2004. 04.004)
95. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. 2008 Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ. Res. 103, 1289-1299. (doi:10.1161/01.RES. 0000338496.95579.56)
96. 2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoural patients. PLoS ONE 7, e42541. (doi:10.1371/journal. pone.0042541)
97. Kwan HY, Huang Y, Yao X. 2007 TRP channels in endothelial function and dysfunction. Biochim. Biophys. Acta 1772, 907-914. (doi:10.1016/j. bbadis.2007.02.013)
98. Cheng HW, James AF, Foster RR, Hancox JC, Bates DO. 2006 VEGF activates receptoroperated cation channels in human microvascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26, 1768-1776. (doi:10.1161/01.ATV.0000231518. 86795.0f)
99. Ge R, Tai Y, Sun Y, Zhou K, Yang S, Cheng T, Zou Q, Shen F, Wang Y. 2009 Critical role of TRPC6 channels in VEGF-mediated angiogenesis. Cancer Lett. 283, 43-51. (doi:10.1016/j.canlet.2009. 03.023)
100. 2+ exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1/2 activation and angiogenic functions of human endothelial cells. J. Biol. Chem. 286, 37 919-37 931.
101. 2+ transport in cancer: close reality or long perspective? Expert Opin. Ther. Targets 17, 225-241. (doi:10.1517/14728222.2013.741594)
102. Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. 2010 What made sesquiterpene lactones reach cancer clinical trials? Drug Discov. Today 15, 668-678. (doi:10.1016/j.drudis.2010.06.002)
103. Denmeade SR, Isaacs JT. 2005 The SERCA pump as a therapeutic target: making a 'smart bomb' for prostate cancer. Cancer Biol. Ther. 4, 14-22. (doi:10.4161/cbt.4.1.1505)